Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prachi Arora

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2025
Effects of semaglutide on one-year medical costs among patients with obesity or overweight in US real world settingPrachi Arora, Wojciech Michalak, Zhenxiang Zhao, et al.
Journal of Comparative Effectiveness Research|May 30, 2018
Factors influencing dabigatran or warfarin medication persistence in patients with nonvalvular atrial fibrillationSrinivas Annavarapu, Pranav K Gandhi, Yong Li, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|January 12, 2026
Real-world healthcare resource utilization and medical costs in patients with overweight or obesity and multimorbidity treated with semaglutide in the United StatesPrachi Arora, Firas Dabbous, Sariya Udayachalerm, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2025
Effects of semaglutide on one-year medical costs among patients with obesity or overweight in US real world settingPrachi Arora, Wojciech Michalak, Zhenxiang Zhao, et al.
Journal of Comparative Effectiveness Research|May 30, 2018
Factors influencing dabigatran or warfarin medication persistence in patients with nonvalvular atrial fibrillationSrinivas Annavarapu, Pranav K Gandhi, Yong Li, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|January 12, 2026
Real-world healthcare resource utilization and medical costs in patients with overweight or obesity and multimorbidity treated with semaglutide in the United StatesPrachi Arora, Firas Dabbous, Sariya Udayachalerm, et al.
Pageof 3